Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β‐cell function and the achievement of the glycated hemoglobin target 1 year after initiation

AIMS/INTRODUCTION: The glucose‐lowering effects of the glucagon‐like peptide‐1 receptor agonist, liraglutide, have been shown to rely on remaining β‐cell function. However, the possible associations of remaining β‐cell function with the glucose‐lowering effects of liraglutide in combination with bas...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Diabetes Investig
Egile Nagusiak: Usui, Ryota, Sakuramachi, Yui, Seino, Yusuke, Murotani, Kenta, Kuwata, Hitoshi, Tatsuoka, Hisato, Hamamoto, Yoshiyuki, Kurose, Takeshi, Seino, Yutaka, Yabe, Daisuke
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031501/
https://ncbi.nlm.nih.gov/pubmed/29106046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12773
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak